Does BREXPIPRAZOLE Cause Product packaging quantity issue? 29 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Product packaging quantity issue have been filed in association with BREXPIPRAZOLE (Rexulti). This represents 0.2% of all adverse event reports for BREXPIPRAZOLE.
29
Reports of Product packaging quantity issue with BREXPIPRAZOLE
0.2%
of all BREXPIPRAZOLE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From BREXPIPRAZOLE?
Of the 29 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BREXPIPRAZOLE. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does BREXPIPRAZOLE Cause?
Weight increased (1,589)
Product use in unapproved indication (1,188)
Off label use (937)
Akathisia (807)
Drug ineffective (730)
Tardive dyskinesia (558)
Tremor (552)
Anxiety (475)
Product use issue (434)
Suicidal ideation (427)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which BREXPIPRAZOLE Alternatives Have Lower Product packaging quantity issue Risk?
BREXPIPRAZOLE vs BREXUCABTAGENE AUTOLEUCEL
BREXPIPRAZOLE vs BRIGATINIB
BREXPIPRAZOLE vs BRILINTA
BREXPIPRAZOLE vs BRILIQUE
BREXPIPRAZOLE vs BRIMONIDINE